HJ Research delivers in-depth insights on the global Genomic Biomarkers market in its upcoming report titled, Global Genomic Biomarkers Market Report 2018-2029. According to this study, the global Genomic Biomarkers market is estimated to be valued at XX Million US$ in 2023 and is projected to reach XX Million US$ by 2029, expanding at a CAGR of XX% during the forecast period. The report on Genomic Biomarkers market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, industrial chain, etc.
This report studies the Genomic Biomarkers market status and outlook of global and major regions, from angles of players, countries, product types and end industries, this report analyzes the top players in global Genomic Biomarkers industry, and splits by product type and applications/end industries. This report also includes the impact of COVID-19 on the Genomic Biomarkers industry.
Global Genomic Biomarkers market: competitive landscape analysis
This report contains the major manufacturers analysis of the global Genomic Biomarkers industry. By understanding the operations of these manufacturers (revenue and gross margin from 2018 to 2023), the reader can understand the strategies and collaborations that the manufacturers are focusing on combat competition in the market.
Global Genomic Biomarkers market: types and end industries analysis
The research report includes specific segments such as end industries and product types of Genomic Biomarkers. The report provides market size for each type and end industry from 2018 to 2023. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Global Genomic Biomarkers market: regional analysis
Geographically, this report is segmented into several key countries, with market size, growth rate of Genomic Biomarkers in these countries from 2018 to 2023, which covering United States, Canada, Germany, France, UK, Italy, Russia, Spain, Netherlands, China, Japan, Korea, India, Australia, Indonesia, Vietnam, Turkey, Saudi Arabia, South Africa, Egypt, Brazil, Mexico, Argentina, Colombia.
Key players in global Genomic Biomarkers market include:
Thermo Fisher Scientific
F. Hoffmann-La Roche
Aepodia
Myriad Genetics
Eurofins Scientific
QIAGEN
Bio-Rad Laboratories
Genomic Health
Liquid Genomics
Epigenomics
AROS Applied Biotechnology A/S
Market segmentation, by product types:
Oncology
Cardiovascular diseases
Neurological diseases
Others
Market segmentation, by applications:
Diagnostic and research laboratories
Hospitals
Others
1 Industry Overview of Genomic Biomarkers
1.1 Research Scope
1.2 Market Segmentation by Types of Genomic Biomarkers
1.3 Market Segmentation by End Users of Genomic Biomarkers
1.4 Market Dynamics Analysis of Genomic Biomarkers
1.4.1 Market Drivers
1.4.2 Market Challenges
1.4.3 Market Opportunities
1.4.4 Porter’s Five Forces
2 Major Manufacturers Analysis of Genomic Biomarkers Industry
2.1 Thermo Fisher Scientific
2.1.1 Company Overview
2.1.2 Main Products and Specifications
2.1.3 Genomic Biomarkers Revenue and Gross Margin (2018-2023)
2.1.4 Contact Information
2.2 F. Hoffmann-La Roche
2.2.1 Company Overview
2.2.2 Main Products and Specifications
2.2.3 Genomic Biomarkers Revenue and Gross Margin (2018-2023)
2.2.4 Contact Information
2.3 Aepodia
2.3.1 Company Overview
2.3.2 Main Products and Specifications
2.3.3 Genomic Biomarkers Revenue and Gross Margin (2018-2023)
2.3.4 Contact Information
2.4 Myriad Genetics
2.4.1 Company Overview
2.4.2 Main Products and Specifications
2.4.3 Genomic Biomarkers Revenue and Gross Margin (2018-2023)
2.4.4 Contact Information
2.5 Eurofins Scientific
2.5.1 Company Overview
2.5.2 Main Products and Specifications
2.5.3 Genomic Biomarkers Revenue and Gross Margin (2018-2023)
2.5.4 Contact Information
2.6 QIAGEN
2.6.1 Company Overview
2.6.2 Main Products and Specifications
2.6.3 Genomic Biomarkers Revenue and Gross Margin (2018-2023)
2.6.4 Contact Information
2.7 Bio-Rad Laboratories
2.7.1 Company Overview
2.7.2 Main Products and Specifications
2.7.3 Genomic Biomarkers Revenue and Gross Margin (2018-2023)
2.7.4 Contact Information
2.8 Genomic Health
2.8.1 Company Overview
2.8.2 Main Products and Specifications
2.8.3 Genomic Biomarkers Revenue and Gross Margin (2018-2023)
2.8.4 Contact Information
2.9 Liquid Genomics
2.9.1 Company Overview
2.9.2 Main Products and Specifications
2.9.3 Genomic Biomarkers Revenue and Gross Margin (2018-2023)
2.9.4 Contact Information
2.10 Epigenomics
2.10.1 Company Overview
2.10.2 Main Products and Specifications
2.10.3 Genomic Biomarkers Revenue and Gross Margin (2018-2023)
2.10.4 Contact Information
2.11 AROS Applied Biotechnology A/S
2.11.1 Company Overview
2.11.2 Main Products and Specifications
2.11.3 Genomic Biomarkers Revenue and Gross Margin (2018-2023)
2.11.4 Contact Information
3 Global Genomic Biomarkers Market Analysis by Regions, Manufacturers, Types and End Users
3.1 Global Sales Revenue of Genomic Biomarkers by Regions (2018-2023)
3.2 Global Sales Revenue of Genomic Biomarkers by Manufacturers (2018-2023)
3.3 Global Sales Revenue of Genomic Biomarkers by Types (2018-2023)
3.4 Global Sales Revenue of Genomic Biomarkers by End Users (2018-2023)
4 Northern America Genomic Biomarkers Market Analysis by Countries, Types and End Users
4.1 Northern America Genomic Biomarkers Sales Revenue Analysis by Countries (2018-2023)
4.2 Northern America Genomic Biomarkers Sales Revenue Analysis by Types (2018-2023)
4.3 Northern America Genomic Biomarkers Sales Revenue Analysis by End Users (2018-2023)
4.4 United States Genomic Biomarkers Sales Revenue Analysis (2018-2023)
4.5 Canada Genomic Biomarkers Sales Revenue Analysis (2018-2023)
5 Europe Genomic Biomarkers Market Analysis by Countries, Types and End Users
5.1 Europe Genomic Biomarkers Sales Revenue Analysis by Countries (2018-2023)
5.2 Europe Genomic Biomarkers Sales Revenue Analysis by Types (2018-2023)
5.3 Europe Genomic Biomarkers Sales Revenue Analysis by End Users (2018-2023)
5.4 Germany Genomic Biomarkers Sales Revenue Analysis (2018-2023)
5.5 France Genomic Biomarkers Sales Revenue Analysis (2018-2023)
5.6 UK Genomic Biomarkers Sales Revenue Analysis (2018-2023)
5.7 Italy Genomic Biomarkers Sales Revenue Analysis (2018-2023)
5.8 Russia Genomic Biomarkers Sales Revenue Analysis (2018-2023)
5.9 Spain Genomic Biomarkers Sales Revenue Analysis (2018-2023)
5.10 Netherlands Genomic Biomarkers Sales Revenue Analysis (2018-2023)
6 Asia Pacific Genomic Biomarkers Market Analysis by Countries, Types and End Users
6.1 Asia Pacific Genomic Biomarkers Sales Revenue Analysis by Countries (2018-2023)
6.2 Asia Pacific Genomic Biomarkers Sales Revenue Analysis by Types (2018-2023)
6.3 Asia Pacific Genomic Biomarkers Sales Revenue Analysis by End Users (2018-2023)
6.4 China Genomic Biomarkers Sales Revenue Analysis (2018-2023)
6.5 Japan Genomic Biomarkers Sales Revenue Analysis (2018-2023)
6.6 Korea Genomic Biomarkers Sales Revenue Analysis (2018-2023)
6.7 India Genomic Biomarkers Sales Revenue Analysis (2018-2023)
6.8 Australia Genomic Biomarkers Sales Revenue Analysis (2018-2023)
6.9 Indonesia Genomic Biomarkers Sales Revenue Analysis (2018-2023)
6.10 Vietnam Genomic Biomarkers Sales Revenue Analysis (2018-2023)
7 Latin America Genomic Biomarkers Market Analysis by Countries, Types and End Users
7.1 Latin America Genomic Biomarkers Sales Revenue Analysis by Countries (2018-2023)
7.2 Latin America Genomic Biomarkers Sales Revenue Analysis by Types (2018-2023)
7.3 Latin America Genomic Biomarkers Sales Revenue Analysis by End Users (2018-2023)
7.4 Brazil Genomic Biomarkers Sales Revenue Analysis (2018-2023)
7.5 Mexico Genomic Biomarkers Sales Revenue Analysis (2018-2023)
7.6 Argentina Genomic Biomarkers Sales Revenue Analysis (2018-2023)
7.7 Colombia Genomic Biomarkers Sales Revenue Analysis (2018-2023)
8 Middle East & Africa Genomic Biomarkers Market Analysis by Countries, Types and End Users
8.1 Middle East & Africa Genomic Biomarkers Sales Revenue Analysis by Countries (2018-2023)
8.2 Middle East & Africa Genomic Biomarkers Sales Revenue Analysis by Types (2018-2023)
8.3 Middle East & Africa Genomic Biomarkers Sales Revenue Analysis by End Users (2018-2023)
8.4 Turkey Genomic Biomarkers Sales Revenue Analysis (2018-2023)
8.5 Saudi Arabia Genomic Biomarkers Sales Revenue Analysis (2018-2023)
8.6 South Africa Genomic Biomarkers Sales Revenue Analysis (2018-2023)
8.7 Egypt Genomic Biomarkers Sales Revenue Analysis (2018-2023)
9 Marketing Channel, Distributors and Traders Analysis
9.1 Marketing Channel
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Distributors and Traders
10 Global Genomic Biomarkers Market Forecast by Regions, Countries, Manufacturers, Types and End Users
10.1 Global Sales Revenue Forecast of Genomic Biomarkers by Regions (2024-2029)
10.2 Global Sales Revenue Forecast of Genomic Biomarkers by Types (2024-2029)
10.3 Global Sales Revenue Forecast of Genomic Biomarkers by End Users (2024-2029)
10.4 Global Revenue Forecast of Genomic Biomarkers by Countries (2024-2029)
10.4.1 United States Revenue Forecast (2024-2029)
10.4.2 Canada Revenue Forecast (2024-2029)
10.4.3 Germany Revenue Forecast (2024-2029)
10.4.4 France Revenue Forecast (2024-2029)
10.4.5 UK Revenue Forecast (2024-2029)
10.4.6 Italy Revenue Forecast (2024-2029)
10.4.7 Russia Revenue Forecast (2024-2029)
10.4.8 Spain Revenue Forecast (2024-2029)
10.4.9 Netherlands Revenue Forecast (2024-2029)
10.4.10 China Revenue Forecast (2024-2029)
10.4.11 Japan Revenue Forecast (2024-2029)
10.4.12 Korea Revenue Forecast (2024-2029)
10.4.13 India Revenue Forecast (2024-2029)
10.4.14 Australia Revenue Forecast (2024-2029)
10.4.15 Indonesia Revenue Forecast (2024-2029)
10.4.16 Vietnam Revenue Forecast (2024-2029)
10.4.17 Brazil Revenue Forecast (2024-2029)
10.4.18 Mexico Revenue Forecast (2024-2029)
10.4.19 Argentina Revenue Forecast (2024-2029)
10.4.20 Colombia Revenue Forecast (2024-2029)
10.4.21 Turkey Revenue Forecast (2024-2029)
10.4.22 Saudi Arabia Revenue Forecast (2024-2029)
10.4.23 South Africa Revenue Forecast (2024-2029)
10.4.24 Egypt Revenue Forecast (2024-2029)
11 Industry Chain Analysis of Genomic Biomarkers
11.1 Upstream Analysis of Genomic Biomarkers
11.2 Downstream Major Consumers Analysis of Genomic Biomarkers
11.3 Major Suppliers of Genomic Biomarkers with Contact Information
11.4 Supply Chain Relationship Analysis of Genomic Biomarkers
12 Genomic Biomarkers New Project Investment Feasibility Analysis
12.1 Genomic Biomarkers New Project SWOT Analysis
12.2 Genomic Biomarkers New Project Investment Feasibility Analysis
12.2.1 Project Name
12.2.2 Investment Budget
12.2.3 Project Product Solutions
12.2.4 Project Schedule
13 Genomic Biomarkers Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.2 References and Data Sources
14.2.1 Primary Sources
14.2.2 Secondary Paid Sources
14.2.3 Secondary Public Sources
14.3 Abbreviations and Units of Measurement
14.4 Author Details
14.5 Disclaimer
Table Types of Genomic Biomarkers
Table End Users of Genomic Biomarkers
Figure Market Drivers Analysis of Genomic Biomarkers
Figure Market Challenges Analysis of Genomic Biomarkers
Figure Market Opportunities Analysis of Genomic Biomarkers
Table Market Drivers Analysis of Genomic Biomarkers
Table Thermo Fisher Scientific Information List
Figure Genomic Biomarkers Specifications of Thermo Fisher Scientific
Table Genomic Biomarkers Revenue (Million USD) and Gross Margin of Thermo Fisher Scientific (2018-2023)
Figure Genomic Biomarkers Revenue (Million USD) and Global Market Share of Thermo Fisher Scientific (2018-2023)
Table F. Hoffmann-La Roche Information List
Figure Genomic Biomarkers Specifications of F. Hoffmann-La Roche
Table Genomic Biomarkers Revenue (Million USD) and Gross Margin of F. Hoffmann-La Roche (2018-2023)
Figure Genomic Biomarkers Revenue (Million USD) and Global Market Share of F. Hoffmann-La Roche (2018-2023)
Table Aepodia Information List
Figure Genomic Biomarkers Specifications of Aepodia
Table Genomic Biomarkers Revenue (Million USD) and Gross Margin of Aepodia (2018-2023)
Figure Genomic Biomarkers Revenue (Million USD) and Global Market Share of Aepodia (2018-2023)
Table Myriad Genetics Information List
Figure Genomic Biomarkers Specifications of Myriad Genetics
Table Genomic Biomarkers Revenue (Million USD) and Gross Margin of Myriad Genetics (2018-2023)
Figure Genomic Biomarkers Revenue (Million USD) and Global Market Share of Myriad Genetics (2018-2023)
Table Eurofins Scientific Information List
Figure Genomic Biomarkers Specifications of Eurofins Scientific
Table Genomic Biomarkers Revenue (Million USD) and Gross Margin of Eurofins Scientific (2018-2023)
Figure Genomic Biomarkers Revenue (Million USD) and Global Market Share of Eurofins Scientific (2018-2023)
Table QIAGEN Information List
Figure Genomic Biomarkers Specifications of QIAGEN
Table Genomic Biomarkers Revenue (Million USD) and Gross Margin of QIAGEN (2018-2023)
Figure Genomic Biomarkers Revenue (Million USD) and Global Market Share of QIAGEN (2018-2023)
Table Bio-Rad Laboratories Information List
Figure Genomic Biomarkers Specifications of Bio-Rad Laboratories
Table Genomic Biomarkers Revenue (Million USD) and Gross Margin of Bio-Rad Laboratories (2018-2023)
Figure Genomic Biomarkers Revenue (Million USD) and Global Market Share of Bio-Rad Laboratories (2018-2023)
Table Genomic Health Information List
Figure Genomic Biomarkers Specifications of Genomic Health
Table Genomic Biomarkers Revenue (Million USD) and Gross Margin of Genomic Health (2018-2023)
Figure Genomic Biomarkers Revenue (Million USD) and Global Market Share of Genomic Health (2018-2023)
Table Liquid Genomics Information List
Figure Genomic Biomarkers Specifications of Liquid Genomics
Table Genomic Biomarkers Revenue (Million USD) and Gross Margin of Liquid Genomics (2018-2023)
Figure Genomic Biomarkers Revenue (Million USD) and Global Market Share of Liquid Genomics (2018-2023)
Table Epigenomics Information List
Figure Genomic Biomarkers Specifications of Epigenomics
Table Genomic Biomarkers Revenue (Million USD) and Gross Margin of Epigenomics (2018-2023)
Figure Genomic Biomarkers Revenue (Million USD) and Global Market Share of Epigenomics (2018-2023)
Table AROS Applied Biotechnology A/S Information List
Figure Genomic Biomarkers Specifications of AROS Applied Biotechnology A/S
Table Genomic Biomarkers Revenue (Million USD) and Gross Margin of AROS Applied Biotechnology A/S (2018-2023)
Figure Genomic Biomarkers Revenue (Million USD) and Global Market Share of AROS Applied Biotechnology A/S (2018-2023)
Table Global Revenue (Million USD) of Genomic Biomarkers by Regions (2018-2023)
Table Global Revenue (Million USD) of Genomic Biomarkers by Manufacturers (2018-2023)
Table Global Revenue (Million USD) of Genomic Biomarkers by Types (2018-2023)
Table Global Revenue (Million USD) of Genomic Biomarkers by End Users (2018-2023)
Table Northern America Genomic Biomarkers Revenue (Million USD) by Countries (2018-2023)
Table Northern America Genomic Biomarkers Revenue (Million USD) by Types (2018-2023)
Table Northern America Genomic Biomarkers Revenue (Million USD) by End Users (2018-2023)
Figure United States Genomic Biomarkers Revenue (Million USD) and Growth Rate (2018-2023)
Figure Canada Genomic Biomarkers Revenue (Million USD) and Growth Rate (2018-2023)
Table Europe Genomic Biomarkers Revenue (Million USD) by Countries (2018-2023)
Table Europe Genomic Biomarkers Revenue (Million USD) by Types (2018-2023)
Table Europe Genomic Biomarkers Revenue (Million USD) by End Users (2018-2023)
Figure Germany Genomic Biomarkers Revenue (Million USD) and Growth Rate (2018-2023)
Figure France Genomic Biomarkers Revenue (Million USD) and Growth Rate (2018-2023)
Figure UK Genomic Biomarkers Revenue (Million USD) and Growth Rate (2018-2023)
Figure Italy Genomic Biomarkers Revenue (Million USD) and Growth Rate (2018-2023)
Figure Russia Genomic Biomarkers Revenue (Million USD) and Growth Rate (2018-2023)
Figure Spain Genomic Biomarkers Revenue (Million USD) and Growth Rate (2018-2023)
Figure Netherlands Genomic Biomarkers Revenue (Million USD) and Growth Rate (2018-2023)
Table Asia Pacific Genomic Biomarkers Revenue (Million USD) by Countries (2018-2023)
Table Asia Pacific Genomic Biomarkers Revenue (Million USD) by Types (2018-2023)
Table Asia Pacific Genomic Biomarkers Revenue (Million USD) by End Users (2018-2023)
Figure China Genomic Biomarkers Revenue (Million USD) and Growth Rate (2018-2023)
Figure Japan Genomic Biomarkers Revenue (Million USD) and Growth Rate (2018-2023)
Figure Korea Genomic Biomarkers Revenue (Million USD) and Growth Rate (2018-2023)
Figure India Genomic Biomarkers Revenue (Million USD) and Growth Rate (2018-2023)
Figure Australia Genomic Biomarkers Revenue (Million USD) and Growth Rate (2018-2023)
Figure Indonesia Genomic Biomarkers Revenue (Million USD) and Growth Rate (2018-2023)
Figure Vietnam Genomic Biomarkers Revenue (Million USD) and Growth Rate (2018-2023)
Table Latin America Genomic Biomarkers Revenue (Million USD) by Countries (2018-2023)
Table Latin America Genomic Biomarkers Revenue (Million USD) by Types (2018-2023)
Table Latin America Genomic Biomarkers Revenue (Million USD) by End Users (2018-2023)
Figure Brazil Genomic Biomarkers Revenue (Million USD) and Growth Rate (2018-2023)
Figure Mexico Genomic Biomarkers Revenue (Million USD) and Growth Rate (2018-2023)
Figure Argentina Genomic Biomarkers Revenue (Million USD) and Growth Rate (2018-2023)
Figure Colombia Genomic Biomarkers Revenue (Million USD) and Growth Rate (2018-2023)
Table Middle East & Africa Genomic Biomarkers Revenue (Million USD) by Countries (2018-2023)
Table Middle East & Africa Genomic Biomarkers Revenue (Million USD) by Types (2018-2023)
Table Middle East & Africa Genomic Biomarkers Revenue (Million USD) by End Users (2018-2023)
Figure Turkey Genomic Biomarkers Revenue (Million USD) and Growth Rate (2018-2023)
Figure Saudi Arabia Genomic Biomarkers Revenue (Million USD) and Growth Rate (2018-2023)
Figure South Africa Genomic Biomarkers Revenue (Million USD) and Growth Rate (2018-2023)
Figure Egypt Genomic Biomarkers Revenue (Million USD) and Growth Rate (2018-2023)
Table Global Revenue (Million USD) Forecast of Genomic Biomarkers by Regions (2024-2029)
Table Global Revenue (Million USD) Forecast of Genomic Biomarkers by Types (2024-2029)
Table Global Revenue (Million USD) Forecast of Genomic Biomarkers by End Users (2024-2029)
Table Major Consumers with Contact Information of Genomic Biomarkers
Table Major Suppliers of Genomic Biomarkers with Contact Information
Figure Supply Chain Relationship Analysis of Genomic Biomarkers
Table New Project SWOT Analysis of Genomic Biomarkers
Table Project Appraisal and Financing
Table New Project Construction Period
Table New Project Investment Feasibility Analysis of Genomic Biomarkers
Table Research Programs/Design for This Report
Table Key Data Information from Primary Sources
Table Key Data Information from Secondary Sources
Table Part of Interviewees Record List of Genomic Biomarkers Industry
Table Part of References List of Genomic Biomarkers Industry
Table Units of Measurement List
Table Part of Author Details List of Genomic Biomarkers Industry
HJ Research employs comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecast possible. At HJ Research, our researchers and domain experts use a unique blend of primary and secondary research, with validation and iterations at every stage, in order to minimize deviation and present the most accurate analysis of the Genomic Biomarkers industry. Critical elements of methodology employed for all our studies include:
Secondary Sources:
The research team first works with national bureau of statistics, national customs, market research association, state information center, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Secondary sources are mainly from press releases, company reports and publications, non-profit organizations, industry associations, government publications, economic and demographic data and customs data. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Primary Research:
In the primary research process, for comprehensive understanding of the Genomic Biomarkers market, it is essential to understand the complete value chain and in order to facilitate this, we collect data from Genomic Biomarkers manufacturers, Genomic Biomarkers raw material suppliers, Genomic Biomarkers distributors as well as buyers. The primary sources from the supply side include Genomic Biomarkers manufacturers, opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the Genomic Biomarkers raw materials suppliers and producers, etc. The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users, and related key executives from various key companies and organizations operating in the global market.
Technical issues and trends are obtained from surveys, technical symposia and trade journals. Technical data is also gathered from intellectual property perspective, focusing on white space and freedom of movement. Industry dynamics with respect to drivers, restraints, pricing trends are also gathered.
Statistical Model and Data Analysis:
Our market estimates and forecasts are derived through simulation models. A unique model is created customized for each study. Gathered information for market dynamics, technology landscape, application development and pricing trends is fed into the model and analyzed simultaneously. These factors are studied on a comparative basis, and their impact over the forecast period is quantified with the help of correlation, regression and time series analysis. Market forecasting is performed via a combination of economic tools, technological analysis, and industry experience and domain expertise. Qualitative analysis includes: Genomic Biomarkers industry landscape and trends, Genomic Biomarkers market dynamics and key issues, Genomic Biomarkers technology landscape, market opportunities, porter’s analysis and PESTEL analysis, Genomic Biomarkers competitive landscape and component benchmarking, policy and regulatory scenario. Quantitative analysis includes: Genomic Biomarkers market size and forecast by regions, Genomic Biomarkers market size and forecast by application, Genomic Biomarkers market size and forecast by types, Genomic Biomarkers company market share etc.
Quality Control:
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the HJ Research’s internal quality process.
